The study evaluated the chemical composition of Citrus bergamia (C. bergamia) essential oil using GC-MS and developed its self-nanoemulsifying system (SNES). The antioxidant, anti-diabetic, anti-obesity, antimicrobial, anticancer, and anti-inflammatory effects were evaluated for the oil and its self-nanoemulsion. Moreover, the docking studies were aided by the AutoDock VINA and Chimera docking software for estimating binding affinities. The main components in C. bergamia essential oil were limonene (34.76%) and linalyl acetate (39.35%). The optimal C. bergamia essential oil SNES formulation has a polydispersity index of 0.215, droplet sizes of 141.44 nm, and a zeta potential of −36 mV, which indicates high stability. The SNES formulation considerably enhanced antioxidant activity, with an IC50 of 7.73 µg/ml compared to 12.03 µg/ml for oil. Comparing the SNES to the oil, it showed better inhibitory activity for α-amylase (IC50 of 50.32 µg/ml and 154.29 µg/ml, respectively) and lipase (IC50 of 34.75 µg/ml and 44.51 µg/ml, respectively). The self-nanoemulsion from C. bergamia demonstrated improved effectiveness against MRSA compared to the essential oil. It showed lower MIC values and better inhibition against all tested bacteria. The selectivity index > 1 is an indication of COX-2 selectivity and boosts the cytotoxic activity against a variety of cancer cell lines. Moreover, molecular docking simulations of these primary constituents exhibited favorable predicted binding affinities for α-amylase, lipase, tryptophan indole-lyase, and COX-2 enzymes. Linalyl acetate (bergamol) showed docking scores of –5.742, –6.738, –4.344, and –6.614 kcal/mol, respectively, while limonene and linalool exhibited comparable binding energies across all targets, ranging from –5.480 to –6.585 kcal/mol. These values were comparable to the positive control scores, providing a mechanistic basis for the oil's multi-target biological activity.
